Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Table of Contents

January 2010; Volume 51,Issue 1
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Abendschein, Dana

    1. You have access
      Molecular Imaging of Atherosclerotic Plaque with 64Cu-Labeled Natriuretic Peptide and PET
      Yongjian Liu, Dana Abendschein, Geoffrey E. Woodard, Raffaella Rossin, Kyle McCommis, Jie Zheng, Michael J. Welch and Pamela K. Woodard
      Journal of Nuclear Medicine January 1, 2010, 51 (1) 85-91; DOI: https://doi.org/10.2967/jnumed.109.066977
  2. Aparici, Carina Mari

    1. You have access
      In Vivo Tumor Grading of Prostate Cancer Using Quantitative 111In-Capromab Pendetide SPECT/CT
      Youngho Seo, Carina Mari Aparici, Matthew R. Cooperberg, Badrinath R. Konety and Randall A. Hawkins
      Journal of Nuclear Medicine January 1, 2010, 51 (1) 31-36; DOI: https://doi.org/10.2967/jnumed.109.067108
  3. Asthana, Pravesh

    1. You have access
      Integrated Software Environment Based on COMKAT for Analyzing Tracer Pharmacokinetics with Molecular Imaging
      Yu-Hua Dean Fang, Pravesh Asthana, Cristian Salinas, Hsuan-Ming Huang and Raymond F. Muzic
      Journal of Nuclear Medicine January 1, 2010, 51 (1) 77-84; DOI: https://doi.org/10.2967/jnumed.109.064824
  4. Avivi, Irit

    1. You have access
      18F-FDG Avidity in Lymphoma Readdressed: A Study of 766 Patients
      Michal Weiler-Sagie, Olga Bushelev, Ron Epelbaum, Eldad J. Dann, Nissim Haim, Irit Avivi, Ayelet Ben-Barak, Yehudit Ben-Arie, Rachel Bar-Shalom and Ora Israel
      Journal of Nuclear Medicine January 1, 2010, 51 (1) 25-30; DOI: https://doi.org/10.2967/jnumed.109.067892
  5. Bailey, Dale L.

    1. You have access
      Combined 18F-FDG and Fluoride Approach in PET/CT Imaging: Is There a Clinical Future?
      Dale L. Bailey
      Journal of Nuclear Medicine January 1, 2010, 51 (1) 165-166; DOI: https://doi.org/10.2967/jnumed.109.066910
  6. Balatoni, Julius

    1. You have access
      124I-Iodopyridopyrimidinone for PET of Abl Kinase–Expressing Tumors In Vivo
      Mikhail Doubrovin, Tatiana Kochetkova, Elmer Santos, Darren R. Veach, Peter Smith-Jones, Nagavarakishore Pillarsetty, Julius Balatoni, William Bornmann, Juri Gelovani and Steven M. Larson
      Journal of Nuclear Medicine January 1, 2010, 51 (1) 121-129; DOI: https://doi.org/10.2967/jnumed.109.066126
  7. Bar-shalom, Rachel

    1. You have access
      18F-FDG Avidity in Lymphoma Readdressed: A Study of 766 Patients
      Michal Weiler-Sagie, Olga Bushelev, Ron Epelbaum, Eldad J. Dann, Nissim Haim, Irit Avivi, Ayelet Ben-Barak, Yehudit Ben-Arie, Rachel Bar-Shalom and Ora Israel
      Journal of Nuclear Medicine January 1, 2010, 51 (1) 25-30; DOI: https://doi.org/10.2967/jnumed.109.067892
  8. Basu, Sandip

    1. You have access
      Combined 18F-FDG and Fluoride Approach in PET/CT Imaging: Is There a Clinical Future?
      Sandip Basu and Ramesh Rao
      Journal of Nuclear Medicine January 1, 2010, 51 (1) 165; DOI: https://doi.org/10.2967/jnumed.109.066860
  9. Ben-arie, Yehudit

    1. You have access
      18F-FDG Avidity in Lymphoma Readdressed: A Study of 766 Patients
      Michal Weiler-Sagie, Olga Bushelev, Ron Epelbaum, Eldad J. Dann, Nissim Haim, Irit Avivi, Ayelet Ben-Barak, Yehudit Ben-Arie, Rachel Bar-Shalom and Ora Israel
      Journal of Nuclear Medicine January 1, 2010, 51 (1) 25-30; DOI: https://doi.org/10.2967/jnumed.109.067892
  10. Ben-barak, Ayelet

    1. You have access
      18F-FDG Avidity in Lymphoma Readdressed: A Study of 766 Patients
      Michal Weiler-Sagie, Olga Bushelev, Ron Epelbaum, Eldad J. Dann, Nissim Haim, Irit Avivi, Ayelet Ben-Barak, Yehudit Ben-Arie, Rachel Bar-Shalom and Ora Israel
      Journal of Nuclear Medicine January 1, 2010, 51 (1) 25-30; DOI: https://doi.org/10.2967/jnumed.109.067892
« Previous (Pages : 1 2 3 4 5 6 ... 17) Next »
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 51 (1)
Journal of Nuclear Medicine
Vol. 51, Issue 1
January 2010
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire